¡®ÀþÀº ¿¬±¸ÀÚ»ó¡¯Àº ´ëÇÑ¿¡ÀÌÁîÇÐȸ¿¡¼ ±¹³» HIV/AIDS ¿¬±¸ Ȱ¼ºÈ¿Í ¿¬±¸ÀÚµéÀÇ Çмú¿¬±¸ ÀÇ¿åÀ» °íÃëÇϱâ À§ÇØ ¼ö¿©ÇÏ´Â »óÀÌ´Ù.
2020³â ´ëÇѰ¨¿°ÇÐȸ¡¤´ëÇÑÇ×±Õ¿ä¹ýÇÐȸÇмúÁö ¡®Infection & Chemotherapy¡¯¿¡ ½Ç¸° ¡®HIV ¾ç¼ºÈ¯ÀÚ¿¡°Ô Åõ¿©ÇÏ´Â Å׳ëÆ÷ºñ¸£ µð¼ÒÇÁ·Ï½Ç Ǫ¸¶¸£»ê¿°(TDF)À» Å׳ëÆ÷ºñ¸£ ¾Ë¶óÆä³ª¹Ìµå Ǫ¸¶¸£»ê¿°(TAF)À¸·Î º¯°æÇÑ ÈÄ ³ªÅ¸³ª´Â ½ÅÀåµ¶¼ºÀÇ º¯È(Recovery of Tenofovir-induced Nephrotoxicity following Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Human Immunodeficiency Virus-Positive Patients)¡¯¸¦ ÁÖÁ¦·Î ÇÑ ¼ÁØ¿ø ±³¼öÀÇ ³í¹®ÀÌ ÃÖ¿ì¼ö³í¹®À¸·Î ¼±Á¤µÆ´Ù.